analyses

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

2 months ago

Artprice News: ahead of Frieze London and Art Basel Paris, Artprice by Artmarket releases its 2025 Contemporary Art Market Report. Annual record number of auction transactions, substantial market paradigm shift, AI influences

PARIS, Oct. 7, 2025 /PRNewswire/ -- With Frieze London about to kick off, followed by Art Basel Paris, Artprice News®…

3 months ago

BingX AI Delivers All-Round Analysis for Better-Informed Trading

PANAMA CITY, Aug. 5, 2025 /PRNewswire/ -- BingX, a leading cryptocurrency exchange and Web3 AI company, announced enhancements of BingX…

5 months ago